Analysts Viewpoint
PROK stock rated a Neutral by JP Morgan
ProKidney Corp’s filing revealed that its Add’l Rep. Persons-see Ex.99-1 Control Empresarial de Capital acquired Company’s shares for reported $0.28
Menu
ProKidney Corp’s filing revealed that its Add’l Rep. Persons-see Ex.99-1 Control Empresarial de Capital acquired Company’s shares for reported $0.28
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
ProKidney Corp’s recent filing unveils that its Add’l Rep. Persons-see Ex.99-1 Control Empresarial de Capital acquired Company’s shares for reported
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
ProKidney Corp’s recent filing unveils that its Add’l Rep. Persons-see Ex.99-1 Control Empresarial de Capital acquired Company’s shares for reported
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
ProKidney Corp’s filing revealed that its Add’l Rep. Persons-see Ex.99-1 Control Empresarial de Capital acquired Company’s shares for reported $0.28
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. ProKidney Corp